Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Head Of Generic Drugs Office Resigns
Pharmalot
Thursday, March 14, 2013 - 10:53am
tags:
generics, FDA
KV Pharma Goes After The FDA, Again
Pharmalot
Thursday, March 14, 2013 - 10:52am
tags:
KV Pharmaceutical, FDA
Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?
Seeking Alpha
Thursday, March 14, 2013 - 10:51am
tags:
Aveo Pharmaceutical, tivozanib, renal cell carcinoma
Cempra: FDA alert on Zithromax will not affect us
Bizjournals.com
Thursday, March 14, 2013 - 10:50am
tags:
FDA, Cempra, Zithromax, antibiotics, Solithromycin
ArQule Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thursday, March 14, 2013 - 10:49am
tags:
earnings, Arqule
FDA wants to relax criteria for Alzheimer's drug approval, NY Times says
Yahoo/Fly on the Wall
Thursday, March 14, 2013 - 10:48am
tags:
Alzheimer's disease, FDA
What's Behind MannKind's Incredible Run?
Motley Fool
Thursday, March 14, 2013 - 8:21am
tags:
MannKind
J&J’s Ekdahl Says Hip Recalled for Clinical Reasons
Bloomberg
Thursday, March 14, 2013 - 8:20am
tags:
JNJ, DePuy, hip impants, recalls
Johnson & Johnson cuts bonuses for new CEO, other execs by 10 percent due to 'disappointments'
Yahoo/AP
Thursday, March 14, 2013 - 8:19am
tags:
JNJ, executive pay
Novartis and Merck Drugs Don’t Stop SARS-Related Virus in Study
Bloomberg
Thursday, March 14, 2013 - 8:17am
tags:
Novartis, Merck, SARS, Galvus
Growing Pains: Pacira Stretched Very Thin Following Exparel Launch
Seeking Alpha
Wednesday, March 13, 2013 - 1:21pm
tags:
Pacira, drug launches, EXPAREL, post-surgical pain, Regeneron, Vertex Pharmaceuticals
GeoVax is On Track to Advance its HIV/AIDS Vaccine Programs in 2013
Yahoo/Zacks
Wednesday, March 13, 2013 - 1:20pm
tags:
GeoVax, HIV, AIDS, vaccines
Sunesis Pharma posts smaller 4th-quarter loss
Yahoo/AP
Wednesday, March 13, 2013 - 1:19pm
tags:
earnings, Sunesis
FTC issues social-media ad rules. Will FDA finally be next?
Fierce Pharma
Wednesday, March 13, 2013 - 1:17pm
tags:
social media, FDA, FTC, drug ads
GlaxoSmithKline to relocate workers as part of consolidation
Bizjournals.com
Wednesday, March 13, 2013 - 1:16pm
tags:
GSK, consolidation, relocation
Merck Intensifies Efforts To Tap The Biologics Market With New R&D Head
Seeking Alpha
Wednesday, March 13, 2013 - 12:56pm
tags:
biologics, Merck, R&D
Spectrum slashes Fusilev sales forecast, and stock tumbles almost 39 percent after-hours
Yahoo/AP
Wednesday, March 13, 2013 - 12:20pm
tags:
Spectrum Pharmaceuticals, Fusilev
Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
Yahoo
Wednesday, March 13, 2013 - 12:19pm
tags:
Receptos, anti-interleukin-13, AbbVie
Keryx CEO vs. a Short-Seller: Zerenex Patent Debate
TheStreet.com
Wednesday, March 13, 2013 - 12:17pm
tags:
Keryx, Zerenex, patents, Amarin
Why Star Scientific Is Poised to Keep Plunging
Motley Fool
Wednesday, March 13, 2013 - 12:16pm
tags:
Star Scientific

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.